As a company listed on the Euronext Growth market in Paris, Europlasma undertakes to providing the financial community with regular, transparent and accessible information and in compliance with stock market regulations
The Board of Directors of Europlasma met today, as part of a warning procedure from its Statutory Auditors, to convene an Ordinary General Meeting to deliberate on the situation of the Company and the continuity of the operation.
